Tyrosine Kinases as Targets for Cancer Therapy

Daniela S. Krause(Johannes Gutenberg University Mainz), Richard A. Van Etten(University of California, Irvine)
New England Journal of Medicine
July 13, 2005
10.1056/nejmra044389
Cited by 1,378

Related Papers

Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F
|PLoS ONE|2006|215
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3
Adult skull bone marrow is an expanding and resilient hematopoietic reservoir
|Research Square|2023|0